Search details
1.
Epidemiology of Huntington's Disease in the United States Medicare and Medicaid Populations.
Neuroepidemiology
; 56(3): 192-200, 2022.
Article
in English
| MEDLINE | ID: mdl-35483335
2.
Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claimsbased retrospective cohort study.
J Med Econ
; 26(1): 862-870, 2023.
Article
in English
| MEDLINE | ID: mdl-37350423
3.
Health care resource utilization and costs among individuals with vs without Huntington disease in a US population.
J Manag Care Spec Pharm
; 28(11): 1228-1239, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36282937
4.
Healthcare resource utilization and costs in individuals with Huntington's disease by disease stage in a US population.
J Med Econ
; 25(1): 722-729, 2022.
Article
in English
| MEDLINE | ID: mdl-35608039
5.
Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder.
J Manag Care Spec Pharm
; 27(2): 223-239, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33506730
6.
Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States.
J Med Econ
; 24(1): 1327-1336, 2021.
Article
in English
| MEDLINE | ID: mdl-34730477
7.
Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
J Manag Care Spec Pharm
; 27(1): 95-104, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33377442
8.
Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids.
J Manag Care Spec Pharm
; 26(1-a Suppl): S2-S10, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31958025
9.
Is There a Relationship Between Part D Medication Adherence and Part C Intermediate Outcomes Star Ratings Measures?
J Manag Care Spec Pharm
; 22(7): 787-95, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-27348279
Results
1 -
9
de 9
1
Next >
>>